• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
The effect of adjuvant cyclophosphamide or tamoxifen on the numbers of lymphocytes bearing T cell or NK cell markers.辅助性环磷酰胺或他莫昔芬对带有T细胞或NK细胞标志物的淋巴细胞数量的影响。
Br J Cancer. 1986 Oct;54(4):705-9. doi: 10.1038/bjc.1986.230.
2
Natural killer cell activity, phagocytosis, and number of peripheral blood cells in breast cancer patients treated with tamoxifen.
Breast Cancer Res Treat. 1994;29(3):279-85. doi: 10.1007/BF00666482.
3
Modulation of natural killer cell activity by tamoxifen in stage I post-menopausal breast cancer.
Eur J Cancer Clin Oncol. 1987 May;23(5):517-20. doi: 10.1016/0277-5379(87)90313-0.
4
The effect of adjuvant tamoxifen: the latest results from the Cancer Research Campaign Adjuvant Breast Trial. Cancer Research Campaign Breast Cancer Trials Group.辅助性他莫昔芬的效果：癌症研究运动辅助性乳腺癌试验的最新结果。癌症研究运动乳腺癌试验小组。
Eur J Cancer. 1992;28A(4-5):904-7.
5
Cyclophosphamide and tamoxifen as adjuvant therapies in the management of breast cancer. CRC Adjuvant Breast Trial Working Party.环磷酰胺和他莫昔芬作为乳腺癌治疗的辅助疗法。CRC辅助性乳腺癌试验工作组。
Br J Cancer. 1988 Jun;57(6):604-7. doi: 10.1038/bjc.1988.137.
6
[Effect of tamoxifen on parameters of cell-mediated immunity in postmenopausal patients with breast carcinoma].[他莫昔芬对绝经后乳腺癌患者细胞介导免疫参数的影响]
Zentralbl Gynakol. 1991;113(12):689-96.
7
Differential effects of chemotherapy-induced and HIV-1-induced immunocompromise on NK and LAK activities using breast cancer and HIV-1 seropositive patient populations.
Anticancer Res. 1991 Mar-Apr;11(2):969-74.
8
Cyclophosphamide-induced eosinophilia in the rat: concomitant changes in T-cell subsets, B cells and large granular lymphocytes within lymphoid tissues.环磷酰胺诱导大鼠嗜酸性粒细胞增多：淋巴组织中T细胞亚群、B细胞和大颗粒淋巴细胞的伴随变化
Immunology. 1987 Mar;60(3):383-8.
9
Start tamoxifen after completing chemotherapy, US researchers say.美国研究人员称，在完成化疗后开始使用他莫昔芬。
Lancet. 2002 Jun 1;359(9321):1925. doi: 10.1016/S0140-6736(02)08789-5.
10
Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.淋巴结阳性乳腺癌女性的辅助全身治疗。乳腺癌护理与治疗临床实践指南指导委员会。
CMAJ. 1998 Feb 10;158 Suppl 3:S52-64.

引用本文的文献

1
Effects of Reishimmune-S, a Fungal Immunomodulatory Peptide Supplement, on the Quality of Life and Circulating Natural Killer Cell Profiles of Patients With Early Breast Cancer Receiving Adjuvant Endocrine Therapy.瑞舒莫德-S（一种真菌免疫调节肽补充剂）对接受辅助内分泌治疗的早期乳腺癌患者生活质量和循环自然杀伤细胞谱的影响。
Integr Cancer Ther. 2024 Jan-Dec;23:15347354241242120. doi: 10.1177/15347354241242120.
2
Polycaprolactone nanofibers as an adjuvant strategy for Tamoxifen release and their cytotoxicity on breast cancer cells.聚己内酯纳米纤维作为他莫昔芬释放的辅助策略及其对乳腺癌细胞的细胞毒性。
PeerJ. 2021 Oct 27;9:e12124. doi: 10.7717/peerj.12124. eCollection 2021.
3
In vivo modulation of natural killer cell activity by tamoxifen in patients with bilateral primary breast cancer.他莫昔芬对双侧原发性乳腺癌患者自然杀伤细胞活性的体内调节作用
Cancer Immunol Immunother. 1993 Aug;37(3):209-12. doi: 10.1007/BF01525437.
4
Influence of adjuvant tamoxifen on blood lymphocytes.
Breast Cancer Res Treat. 1988 Sep;12(1):75-9. doi: 10.1007/BF01805743.
5
Fatty acid modulation of antiestrogen action and antiestrogen-binding protein in cultured lymphoid cells.培养的淋巴细胞中脂肪酸对抗雌激素作用和抗雌激素结合蛋白的调节
Experientia. 1990 Oct 15;46(10):1032-7. doi: 10.1007/BF01940665.
6
The immunological status of breast cancer patients during treatment with a new antiestrogen, toremifene.使用新型抗雌激素药物托瑞米芬治疗期间乳腺癌患者的免疫状态
Cancer Immunol Immunother. 1990;31(6):381-6. doi: 10.1007/BF01741410.

本文引用的文献

1
Augmentation of the human immune response by cyclophosphamide.环磷酰胺增强人体免疫反应。
Cancer Res. 1982 Nov;42(11):4862-6.
2
In vitro effects of 4-hydroperoxycyclophosphamide on human immunoregulatory T subset function. I. Selective effects on lymphocyte function in T-B cell collaboration.4-氢过氧环磷酰胺对人免疫调节性T亚群功能的体外效应。I. 对T-B细胞协作中淋巴细胞功能的选择性效应。
J Exp Med. 1982 Jan 1;155(1):276-90. doi: 10.1084/jem.155.1.276.
3
T lymphocyte subsets in the peripheral blood of patients with benign and malignant breast disease.良性和恶性乳腺疾病患者外周血中的T淋巴细胞亚群。
Br J Cancer. 1983 Feb;47(2):307-9. doi: 10.1038/bjc.1983.41.
4
Potentiation of human cell-mediated and humoral immunity by low-dose cyclophosphamide.低剂量环磷酰胺增强人体细胞介导免疫和体液免疫
Cancer Res. 1984 Nov;44(11):5439-43.
5
Contrasting effects of cyclophosphamide and prednisolone on the phenotype of human peripheral blood leukocytes.环磷酰胺和泼尼松龙对人外周血白细胞表型的对比作用。
Clin Immunol Immunopathol. 1983 Jul;28(1):101-14. doi: 10.1016/0090-1229(83)90193-9.
6
Altered helper and suppressor lymphocyte populations in surgical patients. A measure of postoperative immunosuppression.
Am J Surg. 1984 Sep;148(3):303-7. doi: 10.1016/0002-9610(84)90459-8.
7
Enhancement of dinitrochlorobenzene (DNCB) contact sensitization by cyclophosphamide in the guinea pig.环磷酰胺对豚鼠二硝基氯苯（DNCB）接触致敏的增强作用。
J Invest Dermatol. 1967 Jan;48(1):39-43. doi: 10.1038/jid.1967.6.
8
The relationship of clinical status and therapeutic modality to natural killer cell activity in human breast cancer.
Cancer. 1985 Oct 1;56(7):1543-8. doi: 10.1002/1097-0142(19851001)56:7<1543::aid-cncr2820560713>3.0.co;2-k.
9
Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Analysis at six years by Nolvadex Adjuvant Trial Organisation.
Lancet. 1985 Apr 13;1(8433):836-40.
10
Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes.环磷酰胺敏感的T淋巴细胞抑制抗原特异性细胞毒性T淋巴细胞的体内生成。
J Exp Med. 1977 Feb 1;145(2):455-9. doi: 10.1084/jem.145.2.455.

The effect of adjuvant cyclophosphamide or tamoxifen on the numbers of lymphocytes bearing T cell or NK cell markers.

作者信息

Sheard C R, Reilly F, Tee D E, Vergani D, Lowe D, Baum M, Cameron A E

出版信息

Br J Cancer. 1986 Oct;54(4):705-9. doi: 10.1038/bjc.1986.230.

DOI:10.1038/bjc.1986.230
PMID:3490874
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2001508/
Abstract
摘要